Strong IP keeps collaboration alive, allowing companies to attract capital, strike partnerships, and bring innovations to patients, according to legal experts at Ice Miller.

Tom Wells at 4C Associates, explores the future of biologistics, or how the packaging, storage, and logistics for biologics ...

Leadership means knowing when to jump in and when to let someone else worry about the details, writes Hope Mueller, SVP of Corporate Development and Strategy at Currax Pharmaceuticals.

Women leaders are driving success in life sciences but remain underrepresented and undervalued. That needs to change, writes ...

Part one of a two-part series on FDA Commissioner Martin Makary, M.D.s comments at the Gailen Forum in New York City on October 30, 2025.

Royalty-bearing license agreements are a cornerstone of commercialization in the life sciences and technology industries. Companies often use them to expand their business into new markets while ...

In a candid discussion with members of the media last month, Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) — the organization that birthed Lykos Therapeutics ...

Biopharma leaders are often celebrated for the breakthroughs their companies pursue, from the elegant science to the pioneering modalities and the once-impossible therapies edging closer to reality.

The well-worn adage “good companies are bought, not sold” suggests that top-tier businesses, especially in high-growth industries like life sciences, do not need to seek buyers; instead, buyers pursue ...

Ypsomed, a Swiss developer of injection and infusion systems, is making a significant move into North Carolina’s life sciences landscape with a $249 million investment in Holly Springs. This expansion ...

Navigating a serious diagnosis, chronic condition, or major treatment can be an isolating experience — for both patients and caregivers. Yet, across countless diseases and life challenges, many find ...